A detailed history of Telemetry Investments, L.L.C. transactions in Gritstone Bio, Inc. stock. As of the latest transaction made, Telemetry Investments, L.L.C. holds 105,000 shares of GRTS stock, worth $2,100. This represents 0.57% of its overall portfolio holdings.

Number of Shares
105,000
Holding current value
$2,100
% of portfolio
0.57%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$2.17 - $3.92 $227,850 - $411,600
105,000 New
105,000 $362,000

Others Institutions Holding GRTS

About Gritstone bio, Inc.


  • Ticker GRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,006,896
  • Market Cap $1.46M
  • Description
  • Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...
More about GRTS
Track This Portfolio

Track Telemetry Investments, L.L.C. Portfolio

Follow Telemetry Investments, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Telemetry Investments, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Telemetry Investments, L.L.C. with notifications on news.